Evolution of Liver Transplantation Over the Last 2 Decades Based on a Single-Center Experience of 300 Cases.


Journal

Annals of transplantation
ISSN: 2329-0358
Titre abrégé: Ann Transplant
Pays: United States
ID NLM: 9802544

Informations de publication

Date de publication:
14 Nov 2023
Historique:
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

BACKGROUND Over the past 2 decades, there have been many medical advances in the field of liver transplantation. We conducted this study to evaluate the changes in liver transplantation over the last 2 decades. MATERIAL AND METHODS Three hundred cases of liver transplantation encountered between 1997 and 2019 in Nagasaki University Hospital were divided into 3 groups: Era 1 (cases no. 1-100), Era 2 (cases no. 101-200), and Era 3 (cases no. 201-300). Several items were compared among the groups. RESULTS There were no cases of deceased-donor liver transplantation in Era 1, 1 case in Era 2, and 12 cases in Era 3. The proportion of virus-related disease was significantly lower in Era 3 compared to other eras. In contrast, the proportion of alcoholic liver cirrhosis was significantly higher in Era 3 (27%) than Era 1 (7%) and Era 2 (10%) (P<0.01). In Era 1, the right lobe was selected most frequently, but in Eras 2 and 3, the left lobe was more frequently selected. CONCLUSIONS The evolution of the treatment and the transplant system in Japan is clearly reflected in the indications and types of donors for liver transplantation, even at a single center in Japan.

Identifiants

pubmed: 37957951
pii: 941796
doi: 10.12659/AOT.941796
pmc: PMC10656782
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e941796

Références

Hepatol Res. 2018 Nov;48(12):1045-1054
pubmed: 29908044
Clin Transplant. 2019 Apr;33(4):e13495
pubmed: 30773726
Surg Today. 2008;38(9):795-800
pubmed: 18751944
Ann Surg. 2022 Jan 1;275(1):166-174
pubmed: 32224747
J Gastroenterol. 2017 Aug;52(8):986-991
pubmed: 28138756
Ann Surg. 2019 Jan;269(1):20-27
pubmed: 29303806
Transplantation. 2019 Jan;103(1):109-112
pubmed: 29894414
Liver Transpl. 2018 Mar;24(3):363-368
pubmed: 29194959
Clin Transplant. 2016 May;30(5):518-27
pubmed: 26865166
Clin Transplant. 2017 Nov;31(11):
pubmed: 28881052
Hepatol Res. 2019 Sep;49(9):964-980
pubmed: 31081572
Clin Transplant. 2013 Nov-Dec;27(6):E605-10
pubmed: 23992091
Transplantation. 2018 Aug;102(8):1293-1299
pubmed: 29424768
Hepatol Res. 2016 Dec;46(13):1285-1293
pubmed: 26899352
Transpl Int. 2019 Apr;32(4):356-368
pubmed: 30556935
N Engl J Med. 1996 Mar 14;334(11):693-9
pubmed: 8594428
Surg Today. 2017 Aug;47(8):980-985
pubmed: 28205018
Liver Transpl. 2016 Oct;22(10):1401-7
pubmed: 27343152
Transplant Proc. 2012 Mar;44(2):353-5
pubmed: 22410014

Auteurs

Akihiko Soyama (A)

Department of Surgery, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Takanobu Hara (T)

Department of Surgery, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Hajime Matsushima (H)

Department of Surgery, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Hajime Imamura (H)

Department of Surgery, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Mampei Yamashita (M)

Department of Surgery, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Tomohiko Adachi (T)

Department of Surgery, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Satoshi Miuma (S)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagsaki, Japan.

Hisamitsu Miyaaki (H)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagsaki, Japan.

Kazuhiko Nakao (K)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagsaki, Japan.

Susumu Eguchi (S)

Department of Surgery, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH